Genetic Immunity Receives GMP Certification for in-House Manufacturing Facility
10/8/2012 9:14:19 AM
More...
|
Genetic Immunity Clinical Trial Data Published in PLoS ONE
5/17/2012 9:44:46 AM
More...
|
Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference
12/9/2010 8:39:08 AM
More...
|
Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naive Individuals
7/19/2010 9:39:35 AM
More...
|
Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies – A Unique Nanomedicine for Therapeutic HIV Vaccine
7/12/2010 8:33:49 AM
More...
|
Genetic Immunity Develops Unique Nanomedicine Formulation for DermaVir Therapeutic Vaccine for HIV/AIDS
5/13/2010 9:03:57 AM
More...
|
Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser
5/3/2010 3:17:56 PM
More...
|
Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference – Unique Nanomedicine Formulation and Topical Administration of an HIV/AIDS Therapeutic Vaccine
3/2/2010 3:36:45 PM
More...
|
Genetic Immunity, InPlay: Company Completes Patient Enrollment in Italian Phase II Trial of DermaVir Patch HIV Immunotherapeutic Nanomedicine
7/1/2009 9:48:49 AM
More...
|
Genetic Immunity: Company to Present at Phacilitate Ltd's 8th Annual European Vaccine Forum
6/18/2009 9:51:48 AM
More...
|
|